JUL 14, 2022 8:13 AM PDT

Emerging Research Could Soon Solve the Parkinson's Disease Diagnosis Challenge

WRITTEN BY: Zoe Michaud

Parkinson’s disease is a brain disorder with symptoms that begin gradually and worsen over time. Symptoms of Parkinson’s disease include uncontrollable movements such as shaking and stiffness, and difficulty with balance and coordination.

Since the symptoms of Parkinson’s disease begin gradually, early stages of the disease can be fraught with uncertainty for those suffering from the disease along with their loved ones. There are currently no laboratory tests to diagnose Parkinson’s disease. Instead, cases are diagnosed through a neurological examination and by taking a person’s medical history. 

One known link to Parkinson’s disease is an enzyme called lysosomal glucocerebrosidase (GCase). Reduction in the activity of GCase is linked to the development of Parkinson’s disease. Researchers have been investigating GCase as a therapeutic target and as a potential diagnostic marker. 

By using GCase as a diagnostic marker, clinicians could develop a more definitive benchmark for diagnosing Parkinson’s disease rather than relying on medical history and neurological examination, both of which can result in a misdiagnosis at early stages of the disease. 

Accurately measuring GCase activity within lysosomes has proven to be logistically challenging in previous years. New research from researchers Matthew Deen and Yanping Zhu at Simon Fraser University, which outlines a new method to measure the activity of GCase, could change that.

The researchers use a fluorescence-quenched substrate, coined LysoFQ-GBA, to quantitatively measure GCase activity in tissue samples taken from patients. The researchers propose that clinicians may be able to utilize standard blood samples to detect GCase levels. 

David Vocaldo, co-author of the study, elaborates that “this is the first approach that has been shown to reliably and accurately report on the activity of this enzyme directly within lysosomes of living cells.” 

“Being able to measure the lysosomal activity of this enzyme in an accurate way could be very helpful in understanding the root causes of Parkinson’s as well as potentially helping to diagnose or track its progression,” Vocaldo says. 

Another potential application of this research is in advancing the development of new drugs to treat Parkinson’s disease. Their method could be used to directly monitor whether or not the drug is having the intended effect during clinical trials for drugs that target GCase. 

Sources: National Institutes of Health, Proceedings of the National Academy of Sciences (PNAS), Simon Fraser University

 

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
AUG 04, 2022
Health & Medicine
Researchers Investigate Memory Strategy to Slow Cognitive Decline
AUG 04, 2022
Researchers Investigate Memory Strategy to Slow Cognitive Decline
A team of researchers from University of Michigan and Penn State College of Medicine compared two mnemonic strategies fo ...
AUG 10, 2022
Infographics
Arachnophobia: World's Deadliest Spiders
AUG 10, 2022
Arachnophobia: World's Deadliest Spiders
Spiders are one of nature's most incredible creatures, and there are millions of spider enthusiasts worldwide.
AUG 10, 2022
Health & Medicine
Newly ID'ed Langya Virus Sickens Dozens in China
AUG 10, 2022
Newly ID'ed Langya Virus Sickens Dozens in China
Zoonotic diseases, which can jump from one species to another, are not unusual. As the world's population rises and the ...
AUG 23, 2022
Microbiology
Explaining the Alarming Rise of Superbugs During the Pandemic
AUG 23, 2022
Explaining the Alarming Rise of Superbugs During the Pandemic
With effort, we all can help counter the rise of bacterial pathogens that resist the effects of multiple antibiotics.
AUG 25, 2022
Cancer
Nearly Half of Global Cancer Deaths Attributed to Behavioral Risk Factors
AUG 25, 2022
Nearly Half of Global Cancer Deaths Attributed to Behavioral Risk Factors
Cancer is a broad description of various related diseases resulting from abnormal and excessive cell growth.  While ...
SEP 28, 2022
Health & Medicine
After COVID-19 Infection, Risk of Blood Clots Could Remain for a Year
SEP 28, 2022
After COVID-19 Infection, Risk of Blood Clots Could Remain for a Year
Blood clots are a known risk from a COVID-19 infection. Blood clots are clumps of blood that naturally form to help the ...
Loading Comments...